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In a novel application of dual-channel high-speed
two-photon £uorescence microscopy, the skin auto£uores-
cence and the transdermal £uorescent model drug
spatial distributions were imaged simultaneously over
precisely the same spatial coordinates. The dual chan-
nels enable the detection of the £uorescence emission
wavelengths characteristic of the endogenous (intrinsic)
skin £uorophores, as well as of the rhodamine-based
model drug intensity emission at a di¡erent wavelength
range of the £uorescence emission spectrum. These
£uorescent model drugs delineate the oleic acid induced
changes in permeant di¡usion with respect to the skin
structural features over the 0.3 mm by 0.3 mm skin area
imaged per skin sample. The dual-channel high-speed
two-photon £uorescence microscopy studies presented
here provide evidence for the existence of intracorneo-
cyte di¡usion in addition to the commonly cited lipid
multilamellar transdermal pathway. The image quanti-
¢cation analysis methodology introduced in this paper
reveals that intracorneocyte di¡usion exists for the hy-
drophobic (rhodamine B hexyl ester) and for the hydro-
philic (sulforhodamine B) model drugs, in the absence
of oleic acid chemical enhancer action. The mechanism
of oleic acid chemical enhancer action, however, de-
pends on the model drug physicochemical properties,
where the oleic acid induces hydrophobic model drug
localization to the lipid multilamellar region, while in-
creasing the hydrophilic model drug lipid to corneo-
cyte partitioning. Key words: chemical enhancement
mechanism/dual-channel high-speed two-photon £uorescence
microscopy/oleic acid/skin auto£uorescence. J Invest Dermatol
120:448 ^455, 2003
T
he advantages of using two-photon £uorescence mi-
croscopy to examine a highly scattering and mor-
phologically complex system, such as the skin have
been described previously (Masters et al, 1997, 1998;
Diaspro, 1999; Soeller and Cannell, 1999; Yu et al,
2001), where some of the advantages include reduced sample
photobleaching and increased three-dimensional depth discrimi-
nation. The evaluation of oleic acid-induced transdermal trans-
port has focused in the past on the primary di¡usion pathway
associated with the intercellular lipid region that was well deli-
neated by both the hydrophobic and the hydrophilic model drugs
(Gerritsen and de Grauw, 1999; Yu et al, 2002). In this paper, we
address the role of the corneocytes within the complex stratum
corneum (SC) structure in the case of oleic acid-induced transder-
mal transport.
Until now, the study of chemical enhancer action has focused
primarily on the alteration of the SC barrier properties resulting
from a £uidization of the lipid multilamellar region through
which the permeants di¡use (Golden et al, 1986, 1987). The in-
creased lipid disorder resulting from lipid £uidization has been
cited as being responsible for the increase in drug partitioning
into the SC, as well as for the increase in the porosity of the SC
membrane (Yamashita et al, 1995; Yoneto et al, 1998). Although
chemical enhancer-induced deformation of the corneocytes has
been described in studies using octyl glucoside (Lopez et al,
2000a, b), the role of the corneocyte structures in transdermal
transport processes has been largely neglected, primarily due to
their relative impermeability when compared with that of the
lipid multilamellar region (Matoltsy, 1976).
As a new approach to identify the oleic acid-induced changes
in intracorneocyte model drug penetration, a dual-channel high-
speed two-photon £uorescence microscope (HTPM), used to ¢l-
ter the £uorescence emission wavelengths in the green color spec-
trum range from the red color spectrum range, enables the
simultaneous visualization of the £uorescence signals resulting
from the intrinsic skin auto£uorescence in one channel and those
signals resulting from the exogenous (or externally introduced)
£uorescent model drug in the second channel. In current studies
available in the literature (Grewal et al, 2000;Yu et al, 2001, 2002),
the exogenous model drug £uorescence was examined without
evaluating the corresponding skin auto£uorescence image.
Hence, the £uorescent model drug spatial coordinates were eval-
uated without a visualization of the underlying SC structural fea-
tures that govern the model drug di¡usion pathways. In this
paper, we characterize the exogenous model drug spatial distribu-
tions in the skin with respect to the intrinsic skin auto£uores-
cence at precisely the same skin spatial coordinates.
Skin auto£uorescence has been well studied in the literature,
both in vivo and in vitro (Kollias et al, 1998; Gonzalez et al, 2000;
Na et al, 2001). Using excitation wavelengths ranging from
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340 nm to 380 nm, the skin auto£uorescence emission spectrum
was detected using a £uorescence spectrophotometer that re-
vealed two major component bands centered at 450 nm and 520
nm, that corresponded to 75% and 25% of the total spectrum
intensity, respectively (Na et al, 2000).These two peaks in the skin
auto£uorescence spectrum correspond to the £uorescence emis-
sion peaks of the endogenous (or intrinsic) skin £uorophores, that
include collagen, elastin, aromatic amino acids, such as trypto-
phan and tyrosine, nicotinamideadenine dinucleotide, porphyr-
ins, and £avin adenine dinucleotide (Kollias et al, 1998). The
structural details of the corneocyte^lipid interface, delineated by
imaging the intrinsic skin auto£uorescence, enables the quantita-
tion of model drug spatial distributions relative to the corneocyte
structures in the same skin sample, at precisely the same spatial
locations.
MATERIALS AND METHODS
Skin sample preparation Using the methodology described previously
(Yu et al, 2001, 2002) excised human cadaver skin (National Disease
Research Interchange, Philadelphia, PA) was mounted in side-by-side
di¡usion cells (Permegear, Riegelsville, PA). The model drug control and
enhancer vehicle solutions consisted of 50/50 v/v phosphate-bu¡ered saline/
ethanol and of the control solution containing an additional 5% oleic acid
(Sigma, St Louis, MO), respectively. The hydrophobic and the hydrophilic
model drug concentrations of rhodamine B hexyl ester (RBHE) and
sulforhodamine B (SRB) (Molecular Probes, Eugene, OR), respectively,
were adjusted such that the exogenous £uorescent model drug intensity
signal detected was comparable with the endogenous SC auto£uorescence
intensity. The dilution of the RBHE and SRB vehicles to 0.005 mg per ml
(compared with the 0.33 mg per ml utilized in the studies reported
previously; Yu et al, 2001, 2002) enables the simultaneous imaging of the
skin auto£uorescence as well as of the exogenous £uorescent model drug
intensities, such that model drug signal saturation is avoided. After 24 h of
skin exposure to the model drug solution, the samples were rinsed with
phosphate-bu¡ered saline, and mounted on microscope slides as described
previously (Yu et al, 2002).
HTPM A detailed description of the HTPM methodology utilized in
these studies can be found in the literature (Kim et al, 1999). Modi¢cations
to the HTPM instrumentation include the use of a ¢lter set (Chroma
Technologies, Brattleboro, VT) that separates the £uorescence emission
signal into two wavelength ranges. The ¢lter set consists of a dichroic
mirror (part no. 530DCXR), a short pass ¢lter (part no. E535SP), and a
bandpass ¢lter (part no. D630/40). The dichroic mirror re£ects emission
wavelengths below 530 nm to one channel, where the short pass ¢lter is
applied. Fluorescence emission signals in the range of 610 nm to 650 nm,
that are re£ected from the dichroic mirror, are detected in the second
channel using the bandpass ¢lter. The ¢rst channel collects the emission
wavelengths characteristic of the intrinsic skin £uorophores, and will be
referred to as the green channel. The second channel, or the red channel,
detects the model drug £uorescence signal (Table I lists the absorption and
emission wavelengths of each model drug). The model drug spatial
distributions in the following studies were evaluated in nine consecutive
skin sites, each skin site having an area of 100 mm by 100 mm.
At the laser power used, the skin auto£uorescence intensities treated
with the control and the enhancer vehicle solutions in the presence and in
the absence of the model drugs are comparable. This comparison of the
skin auto£uorescence intensities veri¢es that the skin auto£uorescence
signal detected in the green channel arises from the endogenous skin
£uorophores, and not from signal noise introduced by the model drugs.
Image analysis of model drug spatial distributions To elucidate the
role of intracorneocyte di¡usion in transdermal transport, nine consecutive
skin sites (600 600 pixels in image size) representative of a continuous
skin region containing well de¢ned, regularly spaced corneocytes, were
selected for each skin sample. To focus on the SC structural dimensions
de¢ned by the skin auto£uorescence and by the model drug intensity
signals, a representative subregion, spanning 150150 pixels, was selected
from the total 600 600 pixels skin image acquired for each condition:
RBHE-control, RBHE-enhancer, SRB-control, and SRB-enhancer.
Within each 150150 pixel image, a linear path of 5 pixels in width (y
coordinate) and 150 pixels in length (x coordinate) was deconstructed into
its pixel intensity values to determine the intercellular region width,
de¢ned by the £uorescence intensity peak widths. At each position along
the x coordinate, the intensities of the corresponding 5 pixels were
averaged. The arbitrarily selected line width of 5 pixels accounts for the
intensity variations along the y coordinate while limiting the inclusion of
intensities arising from di¡erent structural features in the average value.
The resulting plot of the £uorescence intensity spectrum for the green
channel, as a function of the x coordinate position, reveals the peak-to-
peak distance as well as the peak width, which indicate the corneocyte
width and the intercellular spacing, respectively, along the 150 pixel linear
region analyzed. The corresponding plot of the model drug £uorescence
intensity spectrum for the red channel describes the model drug spatial
distribution relative to the skin structural features de¢ned by the skin
auto£uorescence intensity spectrum. These skin auto£uorescence and
model drug intensity spectra are then normalized with respect to the
corresponding maximum £uorescence intensities detected within the
selected linear path. Because the skin auto£uorescence and the model
drug £uorescence signals span two di¡erent intensity ranges, the
£uorescence intensity normalization enables a comparison of the relative
changes in the spatial intensity distributions between these two
£uorescence intensity signals using the same normalized scale, where zero
values re£ect the absence of a £uorescence intensity signal and values of 1
represent maximum £uorescence intensity signals.
RESULTS AND DISCUSSION
Visualization of £uorescent model drug spatial distribu-
tions The HTPM dual-channel imaging visualizations of the
skin auto£uorescence and of the exogenous model drug
intensity are presented in Figs 1 and 2 for the hydrophobic
model drug RBHE and for the hydrophilic model drug SRB,
respectively.
Hydrophobic model drug (RBHE) The black regions that
are surrounded by the green intercellular auto£uorescence depict
the corneocyte structures for the control case (see Fig 1a). Based
on the length of the 100 mm scale bar provided at the lower left of
Fig 1(a), the corneocyte dimensions are approximately 30 mm,
which is consistent with the 30^40 mm diameter reported in the
literature (Heisig et al, 1996).
A comparison of the skin auto£uorescence image for the
control RBHE case (Fig 1a) with the RBHE-control model
drug spatial distribution (Fig 1b) indicates that RBHE primarily
traverses the intercellular region. In the overlay of the green and
the red channels shown in Fig 1(c), a majority of the RBHE
signal is observed to be positioned within the intercellular space
delineated by the skin auto£uorescence. In Fig 1(b), the
corneocyte structures exhibit a lower £uorescence intensity
compared with the intercellular lipid multilamellar region
model drug intensity, located at the perimeter of the corneocyte
structures. This ¢nding is consistent with previous studies using
HTPM aimed at elucidating the mechanisms of chemical
enhancer action (Yu et al, 2002). The visualization of RBHE
model drug £uorescence within the periphery of the corneocyte
structures, however, indicates that intracorneocyte di¡usion may
result from the £uorescent model drug concentration di¡erence
between the intercellular region and the £uorescent model drug
de¢cient corneocyte interior.
The oleic acid-induced changes in the RBHE spatial
distribution are observed upon comparing Fig 1(d,e). The
Table I. Fluorescent model drug properties of the hydro-
phobic (RBHE) and the hydrophilic (SRB) model drugs
examined.a
Probe RBHE SRB
MW (Da) 627 559
ab/em (nm) 556/578 565/586
log KbO/PBS 2.4970.18 0.457.0045
aMW is the molecular weight of each probe; ab/em indicates the probe spectral
absorption (ab) and emission peaks (em); logK O/PBS, re£ects the measured values
of the log of the probe PBS-octanol partition coe⁄cients (Yu et al., 2001).
bValues are reported as mean7SD. Experiments were performed in triplicate
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overlap of the green and the red channels, shown in Fig 1(f),
indicates con¢nement of the RBHE signal position to the
intercellular region de¢ned by the skin auto£uorescence image
(Fig 1d). Furthermore, the oleic acid induced formation of the
hydrophobic drug microdomains are observed at the upper and
at the lower bright, white, regions of Fig 1(e). Compared
with the control case (Fig 1b), these microdomains observed
in the enhancer case contribute to increased heterogeneity in
the model drug spatial distribution. A comparison of the
skin auto£uorescence (Fig 1d) with the oleic acid-induced
Figure1. Visualization of the £uorescence intensity of: (a) the skin auto£uorescence (green DHTPM channel); (b) the RBHE model drug
intensity (red DHTPM channel); and (c) the model drug signal-auto£uorescence overlay for the control case, at the same skin spatial coor-
dinates.The corresponding images for the chemical enhancer (oleic acid) case are shown in (d), (e), and (f), respectively. The skin auto£uorescence intensity
is depicted by the green color bar, where increasing intensities correspond to brighter green colors. AF0¼ 0 counts per pixel, whereas AFn¼100 counts per
pixel. The model drug intensities are re£ected in the red scale color bar, where regions in black indicate low model drug concentration and regions of high
model drug concentration are represented by white. The intensities displayed for the RBHE model drug range from I0¼ 0 counts per pixel to In¼1000
counts per pixel.
450 YU ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
hydrophobic model drug spatial distribution (Fig 1e) indicates a
decrease in the model drug intracorneocyte penetration with
respect to the control case.
Hydrophilic model drug (SRB) Figure 2(a) shows the SC
auto£uorescence signal for the hydrophilic model drug (SRB)
control case. The corneocytes are the dark polyhedral regions
surrounded by the green auto£uorescence of the SC intercellular
region. The similarity in skin auto£uorescence intensity
distributions for the hydrophobic model drug (Fig 1a) and for
the hydrophilic model drug (Fig 2a) control cases indicates that
the intrinsic SC auto£uorescence is independent of model drug
speci¢c penetration pathways. The £uorescent model drug spatial
distributions can therefore be characterized relative to these maps
of the intrinsic skin structural features.
The SRB model drug spatial distribution shown in Fig 2(b)
further highlights the intercellular di¡usion pathway speci¢c to
the physicochemical properties of the hydrophilic £uorescent
Figure 2. Visualization of the £uorescence intensity of: (a) the skin auto£uorescence (green DHTPM channel); (b) the SRB model drug
intensity (red DHTPM channel); and (c) the model drug signal-auto£uorescence overlay for the control case, at the same skin spatial
coordinates. The corresponding images for the chemical enhancer (oleic acid) case are shown in (d), (e), and (f ), respectively. AF0¼ 0 counts per pixel,
whereas AFn¼ 50 counts per pixel. The range of SRB model drug intensities shown by the color bar range from I0¼ 0 counts per pixel to In¼ 200 counts
per pixel (in panel b) and I0¼ 0 counts per pixel to In¼1000 counts per pixel (in panel e).
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model drug. As observed in the wide-area visualization of
hydrophilic model drug SRB distributions reported in a
previous paper (Yu et al, 2002), SRB lies primarily within the
intercellular region. The overlapping of the £uorescence signals
from the green and the red channels shown in Fig 2(c) further
demonstrates that the SRB model drug spatial distribution is
primarily located within the intercellular region de¢ned by the
skin auto£uorescence. The appearance of SRB model drug
intensity within the corneocyte region provides evidence for
hydrophilic model drug penetration into the corneocyte region.
As described earlier for the RBHE-control case, the SRB
intracorneocyte di¡usion, visualized in Fig 2(b), may be
attributed to the model drug concentration di¡erence between
the primary hydrophilic model drug transport pathway of the
intercellular region and the model drug-de¢cient corneocyte
regions.
In the presence of oleic acid chemical enhancer action,
increased hydrophilic model drug intensities were visualized
within the corneocyte region. Compared with the
corresponding auto£uorescence signals, the oleic acid-induced
SRB spatial distribution detected in the red channel (see Fig 2e)
highlights a continuous phase that is broader than the one
detected in the green channel (see Fig 2d). Overlapping the
signals detected in the red and the green channels indicates
the extent of SRB intracorneocyte penetration (Fig 2f), where
the £uorescence signal detected through the red channel extends
into the corneocyte regions outlined by the green channel.
A quanti¢cation of the observations made above is presented
below.
Linear image deconstruction of intracorneocyte model drug
intensity distributions For each skin sample, Figs 3 and 4
capture the linear deconstruction paths examined within the
context of the surrounding 150150 pixel skin area. The
£uorescence intensity spectra shown for the RBHE-control, the
RBHE-enhancer, the SRB-control, and the SRB-enhancer cases
in Figs 3(b), 3(e), 4(b), and 4(e), respectively, represents the
deconstruction of the £uorescence images along one dimension
(see Materials and Methods above).
Hydrophobic model drug (RBHE) For the RBHE-control
in Fig 3(b), the model drug intensity spectrum (red line)
envelopes the auto£uorescence spectrum (green line). The wider
model drug intensity spectrum peaks, relative to the referenced
peak widths of the corresponding auto£uorescence spectrum,
indicate that the model drug transport extends beyond the
intercellular region de¢ned by the skin auto£uorescence
intensity spectrum and into the corneocyte structures.
Compared with the zero intensity minima exhibited by the skin
auto£uorescence spectrum, the model drug intensity spectrum
minima never approach zero. The model drug intensities
detected within the corneocyte regions further corroborate the
existence of intracorneocyte model drug penetration potentially
driven by the model drug concentration gradient from the
intercellular region into the corneocyte region.
In the presence of oleic acid, however, RBHE becomes
localized to within the de¢ned intercellular space. The intensity
spectra shown in Fig 3(e) indicate that the widths of the
auto£uorescence intensity peaks (located at x¼ 60 pixels and
at x¼140 pixels) extend beyond the corresponding peak
widths for the model drug intensity spectrum. In enhancing
transdermal transport of the hydrophobic model drug, the
action of the oleic acid chemical enhancer is observed in the
localization of the RBHE distribution, ¢rst to the intercellular
region, and second, to the larger domains of high model
drug intensity (white regions at the top and at the bottom of
Fig 1e), referred to earlier as microdomains of model drug
distribution.
Hydrophilic model drug (SRB) Figure 4(b) shows the
SRB-control sample intensity spectrum (red line),
corresponding to the white rectangle highlighted in Fig 4(a),
and the auto£uorescence spectrum (green line), corresponding
to the white rectangle highlighted in Fig 4(c). In Fig 4(b), the
SRB-control auto£uorescence spectrum (green line) exhibits
two major peaks at x¼ 21 pixels and at x¼103 pixels, with
minor peaks at x¼ 56 pixels and at x¼150 pixels. These four
peaks correspond to the positions of the intercellular regions
shown in the white rectangle demarking the linear
path evaluated in the corresponding skin auto£uorescence image
(Fig 4c).
The SRB model drug intensity spectrum peak widths (see red
line in Fig 4b) are greater than those corresponding to the skin
auto£uorescence peaks (see green line in Fig 4b) at the four x-
coordinates noted. This di¡erence between the model drug
intensity and the skin auto£uorescence peak widths indicates
that the model drug does penetrate into the corneocyte region,
although not to the same extent as for the SRB-enhancer case
(described below). The minima corresponding to the SRB-
control intensity spectrum in Fig 4(b) (see red line at x¼ 40
and 75 pixels) do reach the zero intensity value as the spatial
position approaches the corneocyte center and away from the
intercellular region. The additional peak detected only for the
model drug intensity at x¼120 pixels provides evidence of
model drug penetration into the corneocyte region. The peak-
to-peak region of the auto£uorescence spectrum (see green line
in Fig 4b) from x¼103^150 pixels outlines the outer bounds of
a corneocyte. The model drug intensity peak at x¼120 pixels, as
well as the nonzero model drug intensities detected within the
corresponding corneocyte region (see red line in Fig 4b from
x¼103^150 pixels), indicate model drug penetration within this
corneocyte region. Compared with the di¡erences between the
hydrophobic model drug peak widths and their corresponding
auto£uorescence peak widths, the hydrophilic model drug
control case displays less intracorneocyte di¡usion.
The oleic acid-induced increase in the penetration of the
hydrophilic model drug (SRB) into the corneocyte region is
observed in the spectra shown in Fig 4(e), in which the model
drug peak widths far exceed the auto£uorescence peak widths
that outline the boundary of the intercellular region. The oleic
acid-induced increased partitioning of SRB into the SC
intercellular region, which was quanti¢ed previously (Yu et al,
2001, 2002), increases the model drug concentration in the
intercellular region. The drop in model drug intensity (red line
in Fig 4e) about the peak maximum re£ects the concentration
gradient driving SRB di¡usion into the corneocytes. In contrast
to its e¡ect on the hydrophobic model drug localization to the
intercellular region, the increased concentration of SRB in the
intercellular region contributes to the oleic acid-induced
intracorneocyte penetration observed in Fig 4(d), where the
model drug intensity does not drop to zero in the corneocyte
regions.
Based on the visual elucidation of transport pathways through
the decomposition of the skin auto£uorescence signals from the
model drug £uorescence signal, oleic acid was observed to
increase intracorneocyte penetration for the hydrophilic model
drug and to localize hydrophobic model drug di¡usion to either
the intercellular region or to the larger domains (‘‘pools’’) of high
model drug intensity.
Implications of the role of corneocyte di¡usion on
transdermal transport The oleic acid-induced increase in
SRB lipid to corneocyte partitioning is observed in the model
drug di¡usion into the corneocytes. The availability of
corneocyte di¡usion as a secondary pathway suggests that the
constraints to transdermal transport via lateral di¡usion through
the tortuous intercellular multilamellae no longer hold.
Therefore, the oleic acid-induced increase in SRB model drug
di¡usion into the corneocytes remains consistent with earlier
¢ndings that the hydrophilic model drug vehicle to SC
partitioning is the rate-limiting step (Yu et al, 2002).
Furthermore, the hydrophobic model drug rate-limiting step of
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lateral di¡usion coincides with the oleic acid-induced localization
of the hydrophobic model drug to domains within the
intercellular region. This conclusion remains consistent
with the transport hindrance presented by the tortuous lipid
multilamellae region for the hydrophobic model drugs
established earlier by Johnson et al (1997), and more recently Yu
et al (2002).
For the hydrophobic model drug, the model drug localization
to the intercellular region, as well as to discrete domains within
the SC, could be attributed to the inherent model drug
preference for the oily environment of the lipoidal region and
the inherent model drug dislike for the hydrophilic corneocyte
interior. Therefore, the oleic acid is observed to increase the
hydrophobic model drug solubility in the lipid region, while
decreasing the hydrophobic model drug penetration into the
corneocyte region. The increased model drug concentrations in
the lipoidal region of the SC, resulting from increased model
drug partitioning, are localized to the intercellular region such
that hydrophobic model drug di¡usion is con¢ned to lateral
di¡usion.
Figure 3. Peak-width image analysis of the hydrophobic model drug (RBHE) intensity spectrum. For the control case, the linear £uorescence
intensity deconstruction regions are demarked by the white rectangles in the images of the RBHE model drug spatial distribution, shown in (a), and of the
corresponding skin auto£uorescence signal, shown in (c).The green and the red lines in (b) represent the skin auto£uorescence and the model drug intensity
spectra, respectively. For the chemical enhancer (oleic acid) case, the white rectangles in (d) and (f ) show the linear £uorescence intensity deconstruction
regions for the images of the model drug spatial distribution and of the skin auto£uorescence, respectively. The green and the red lines shown in (e) depict
the intensity spectra for the skin auto£uorescence and for the model drug, respectively. See the text for details.
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For the hydrophilic model drug, however, a di¡erent
mechanism of transport enhancement was observed.
The oleic acid-induced increases in hydrophilic model drug
partitioning into the SC lipid multilamellar region drives
the hydrophilic model drug from the lipid region into the
hydrophilic corneocyte interior. Whereas circumventing
transport into the corneocytes promoted hydrophobic
model drug transport, transport enhancement for the
hydrophilic model drug resulted in increased intracorneocyte
di¡usion.
CONCLUSIONS
The application of DHTPM to delineate the oleic acid-induced
changes in the permeant transdermal pathways has been intro-
duced to elucidate the mechanisms of chemical enhancer action.
Oleic acid was found to induce increases in the SRB intracorneo-
cyte di¡usion and in the localization of the RBHE model drug
di¡usion to the intercellular region.
Although the extent of lipid to corneocyte partitioning de-
pends, in part, on the speci¢c physicochemical properties of the
Figure 4. Peak-width image analysis of the hydrophilic model drug (SRB) intensity spectrum. For the control case, the linear £uorescence in-
tensity deconstruction regions are outlined by the white rectangles in the images of the SRB model drug spatial distribution, shown in (a), and of the
corresponding skin auto£uorescence signal, shown in (c).The green and the red lines in (b) represent the skin auto£uorescence and the model drug intensity
spectra, respectively. For the chemical enhancer (oleic acid) case, the white rectangles in (d) and (f) show the linear £uorescence intensity deconstruction
regions for the images of the model drug spatial distribution and of the skin auto£uorescence, respectively. The green and the red lines shown in (e) depict
the intensity spectra for the skin auto£uorescence and for the model drug, respectively. See the text for details.
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hydrophobic and the hydrophilic model drugs, the mechanistic
insight provided here poses the question of how localizing the
chemically induced enhancement of transdermal permeant di¡u-
sion to the intercellular region may further increase the skin per-
meabilities to hydrophilic permeants currently achieved with
well-known, e¡ective chemical enhancer formulations. The dual
function of the corneocytes in the scheme of chemically induced
transdermal transport warrants further analyses. In particular, the
precise role of intracorneocyte di¡usion in enhancing or hinder-
ing transport remains to be elucidated.
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